| 摘要 |
This invention provides methods, pharmacodynamics biomarker signatures for multiple signaling pathways in a cell, sample such as anagen hair, in response to carboxyamidotriazole orotate (CTO) from a subject CTO has demonstrated response in several cancers having different genomic mutations m clinical studies. This invention provides a diagnostic and prognostic assay for monitoring response to CTO ranging from - l00fold to +25 fold differential expression in several transcriptional signatures associated with tumor inhibition including EGFR, MEK, HDAC, RAS, GFS, WNT, HSP90 or non-voltage dependent calcium signaling, while inducing tumor suppressors signatures such as P53 or EGR1 in the anagen hair assay. |
